Canadian General Medical Center Complex Company (9518.SR)
SAR 6.3
(0.96%)
SAR 6.3
(0.96%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 12.76 Million | 16.52 Million | 1.59 Million | 17.82 Million | 20.96 Million |
| Net Income | 17.86 Million | 17.97 Million | 16.52 Million | 16.71 Million | 14.87 Million |
| Depreciation & Amortization | 1.73 Million | 3.14 Million | 2.93 Million | 2.83 Million | 1.39 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -11.03 Million | -2.93 Million | -18.12 Million | -2.88 Million | 3.98 Million |
| Other non-cash items | 4.2 Million | -1.64 Million | 243.78 Thousand | 1.17 Million | -684.25 Thousand |
| Investing Cash Flow | 42.62 Million | 14.55 Million | -60.62 Million | -1.09 Million | -2.6 Million |
| Investments in PPE | -3.37 Million | -101.4 Thousand | -1.63 Million | -1.09 Million | -2.6 Million |
| Acquisitions | 81.45 Thousand | -14.65 Million | 6929.00 | 884.00 | 1137.00 |
| Investment purchases | -81.45 Thousand | -55 Million | -59 Million | - | - |
| Sales/Maturities of investments | 45.92 Million | 69.65 Million | -6929.00 | - | - |
| Other Investing Activities | 81.45 Thousand | 14.65 Million | 6929.00 | 884.00 | - |
| Financing Cash Flow | -12.69 Million | -26.94 Million | -14.36 Million | 60.93 Million | -16.53 Million |
| Debt repayment | -1.14 Million | -2.75 Million | -1.86 Million | -748.74 Thousand | -31.94 Thousand |
| Dividends payments | -11.55 Million | -23.1 Million | -11.55 Million | -12.36 Million | -16.01 Million |
| Common Stock Repurchased | - | - | - | 748.74 Thousand | - |
| Common Stock Issuance | - | - | - | 75 Million | - |
| Other Financing Activities | -1.14 Million | -1.08 Million | -953.88 Thousand | -1.7 Million | -557.2 Thousand |
| Accounts receivables | -12.13 Million | -906.99 Thousand | -18.38 Million | -718.73 Thousand | 3.13 Million |
| Accounts payables | 672.11 Thousand | 616.17 Thousand | 1.97 Million | -2.08 Million | 1.07 Million |
| Inventory | 434 Thousand | -2.64 Million | -1.71 Million | -79.89 Thousand | -27.11 Thousand |
| Other working capital | -1.88 Million | -466.51 Thousand | -267.9 Thousand | -192.17 Thousand | -196.84 Thousand |
| Cash at beginning of period | 10.65 Million | 6.51 Million | 79.91 Million | 2.25 Million | 438.27 Thousand |
| Cash at end of period | 53.36 Million | 10.65 Million | 6.51 Million | 79.91 Million | 2.25 Million |
| Capital Expenditure | -3.37 Million | -101.4 Thousand | -1.63 Million | -1.09 Million | -2.6 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 42.7 Million | 4.14 Million | -73.4 Million | 77.66 Million | 1.81 Million |
| Free Cash Flow | 9.39 Million | 16.42 Million | -45.48 Thousand | 16.73 Million | 18.35 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.68 Million | 1.68 Million | 7.7 Million | 17.86 Million | 3.85 Million | 8 Million |
| Depreciation & Amortization | 880.89 Thousand | 880.89 Thousand | 541.18 Thousand | 1.73 Million | 270.59 Thousand | 1.19 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -3.38 Million | -3.38 Million | -6.61 Million | -11.03 Million | -3.38 Million | -6.3 Million |
| Other non-cash items | 2.93 Million | 2.93 Million | 13.32 Million | 4.2 Million | 3.28 Million | 9.42 Million |
| Investing Cash Flow | -1.38 Million | -1.38 Million | -2.76 Million | 42.62 Million | -1.38 Million | 45.39 Million |
| Investments in PPE | -1.41 Million | -1.41 Million | -2.82 Million | -3.37 Million | -1.41 Million | -543.57 Thousand |
| Acquisitions | 50 Thousand | - | 64.92 Thousand | 81.45 Thousand | - | 16.52 Thousand |
| Investment purchases | - | - | - | -81.45 Thousand | - | -22.96 Million |
| Sales/Maturities of investments | - | - | - | 45.92 Million | - | 45.92 Million |
| Other Investing Activities | 25 Thousand | 25 Thousand | 32.46 Thousand | 81.45 Thousand | 32.46 Thousand | 22.96 Million |
| Financing Cash Flow | -4.66 Million | -4.66 Million | -8.1 Million | -12.69 Million | -4.05 Million | -4.58 Million |
| Debt repayment | - | - | - | -1.14 Million | - | - |
| Dividends payments | -6.93 Million | -3.46 Million | -7.7 Million | -11.55 Million | -3.85 Million | -3.85 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.19 Million | -1.19 Million | -204.99 Thousand | - | -204.99 Thousand | -365 Thousand |
| Accounts receivables | -1.42 Million | -1.42 Million | -8.09 Million | -12.13 Million | -3.78 Million | -4.04 Million |
| Accounts payables | 6.37 Million | - | 1.14 Million | 672.11 Thousand | - | -471.02 Thousand |
| Inventory | -368.13 Thousand | -368.13 Thousand | 1.11 Million | 434 Thousand | 559.85 Thousand | -685.71 Thousand |
| Other working capital | -1.59 Million | -1.59 Million | -790.37 Thousand | -1.88 Million | -160.48 Thousand | -1.09 Million |
| Cash at beginning of period | 53.36 Million | - | 56.18 Million | 10.65 Million | - | 10.65 Million |
| Cash at end of period | 45.48 Million | -3.93 Million | 53.36 Million | 53.36 Million | -1.41 Million | 56.18 Million |
| Capital Expenditure | -1.41 Million | -1.41 Million | -2.82 Million | -3.37 Million | -1.41 Million | -543.57 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -7.87 Million | -3.93 Million | -2.82 Million | 42.7 Million | -1.41 Million | 45.53 Million |
| Free Cash Flow | 700.02 Thousand | 700.02 Thousand | 5.21 Million | 9.39 Million | 2.6 Million | 4.17 Million |
4949
BWPC
LAL
ASCN
UDS
IINNW